Tempus AI (NASDAQ:TEM) Upgraded to Hold at Rothschild & Co Redburn

Key Points

• Rothschild & Co. Redburn upgraded Tempus AI to “hold,” while the broader analyst consensus remains “hold,” with an average price target of $68.71.
• Tempus AI reported quarterly revenue of $382.49 million, up 21.6% year over year, and an adjusted loss of $0.04 per share that beat analyst expectations; shares opened at $64.29.
• Insiders sold more than 1.04 million shares worth approximately $57 million over the past 90 days, including stock sales by CEOs Eric Lefkofsky and Ryan Fukushima under pre-arranged trading plans.

Tempus AI (NASDAQ:TEM - Get Free Report) was upgraded by analysts at Rothschild & Co Redburn to a "hold" rating in a note issued to investors on Tuesday, Zacks reports.

Several other research analysts have also recently issued reports on TEM. Lake Street Capital cut Tempus AI to a "hold" rating in a research report on Monday, July 20th. BTIG Research upped their price target on shares of Tempus AI from $70.00 to $80.00 and gave the stock a "buy" rating in a research note on Thursday, August 20th. Piper Sandler upgraded shares of Tempus AI from a "neutral" rating to an "overweight" rating and increased their price target for the company from $56.00 to $76.00 in a report on Tuesday, September 1st. Roth Capital began coverage on shares of Tempus AI in a research note on Tuesday. They issued a "neutral" rating and a $67.00 price objective for the company. Finally, Wolfe Research initiated coverage on shares of Tempus AI in a report on Tuesday, June 2nd. They set a "peer perform" rating on the stock. Eleven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average price target of $68.71.

Tempus AI Trading Down 0.5%

NASDAQ TEM opened at $64.29 on Tuesday. The company has a quick ratio of 3.16, a current ratio of 3.30 and a debt-to-equity ratio of 3.06. The stock has a market capitalization of $11.60 billion, a P/E ratio of -44.65 and a beta of 3.72. Tempus AI has a 52-week low of $40.77 and a 52-week high of $104.32. The firm has a 50-day moving average price of $56.03 and a 200 day moving average price of $52.27.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported ($0.04) earnings per share for the quarter, beating analysts' consensus estimates of ($0.14) by $0.10. The company had revenue of $382.49 million for the quarter, compared to analyst estimates of $379.69 million. Tempus AI had a negative return on equity of 50.28% and a negative net margin of 17.77%.The firm's revenue for the quarter was up 21.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.22) EPS. Equities research analysts expect that Tempus AI will post -1.38 EPS for the current year.

Insider Activity at Tempus AI

In other news, CEO Eric P. Lefkofsky sold 11,848 shares of the firm's stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $69.87, for a total value of $827,819.76. Following the completion of the transaction, the chief executive officer owned 150,000 shares in the company, valued at $10,480,500. This trade represents a 7.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Ryan Fukushima sold 14,286 shares of Tempus AI stock in a transaction on Friday, August 21st. The stock was sold at an average price of $70.00, for a total value of $1,000,020.00. Following the transaction, the chief executive officer directly owned 47,420 shares of the company's stock, valued at $3,319,400. This trade represents a 23.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,043,988 shares of company stock valued at $56,963,417 in the last 90 days. 24.26% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Tempus AI

A number of large investors have recently added to or reduced their stakes in TEM. JPL Wealth Management LLC acquired a new position in Tempus AI during the third quarter worth about $26,000. Los Angeles Capital Management LLC purchased a new position in shares of Tempus AI during the 4th quarter worth approximately $27,000. Harvest Fund Management Co. Ltd purchased a new position in shares of Tempus AI during the 3rd quarter worth approximately $38,000. EMC Capital Management acquired a new position in shares of Tempus AI during the 2nd quarter worth approximately $29,000. Finally, Danske Bank A S acquired a new position in shares of Tempus AI during the 3rd quarter worth approximately $48,000. 24.22% of the stock is owned by institutional investors and hedge funds.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company's core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.